CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis-Reference-Cited by-同舟云学术

CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis

Published:2016-11-23 Issue:2 Volume:94 Page:312-326
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Singleton B. K.¹,Ahmed M.²,Green C. A.¹,Heimpel H.³,Woźniak M. J.¹,Ranjha L.¹,Seeney F.⁴,Bomford A.⁵,Mehta P.⁶,Guest A.⁷,Mushens R.⁷,King M.-J.⁷

Affiliation:

1. Bristol Institute for Transfusion Sciences, NHS Blood and Transplant; Bristol UK

2. Department of Haematology; University College London Cancer Institute; London UK

3. German Registry on Congenital Dyserythropoietic Anaemias, Medizinishe; Universitätsklinik III; Ulm Germany

4. Statistics and Clinical Studies; NHS Blood and Transplant; Bristol UK

5. Institute of Liver Studies, King's College Hospital NHS Foundation Trust; London UK

6. Department of Haematology; Bristol Royal Infirmary, North Bristol NHS Trust; UK

7. International Blood Group Reference Laboratory; NHS Blood and Transplant; Bristol UK

Funder

NIHR BTRU and the NHSBT (see Acknowledgment). National Institute for Health Research Blood and Transplant Unit (NIHR BTRU), in Red Blood Cell Products Unit, of University of Bristol, & NHSBT

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference46 articles.

1. Frequency of congenital dyserythropoietic anemias in Europe;Heimpel;Euro J Haematol,2010

2. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: Definition of clinical and molecular spectrum and identification of new diagnostic scores;Russo;Am J Hematol,2014

3. E109K is a SEC23B founder mutation among Israeli Morrocan Jewish patients with congenital dyserythropoietic anemia type II;Amir;Acta Haematol,2011

4. Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anaemia type II;Singleton;Clin Genet,2015

5. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders;King;Int J Lab Hematol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem Cell Transplant of a Congenital Dyserythropoietic Anemia Type II Patient: A Rare Report from the Indian Population;Indian Journal of Hematology and Blood Transfusion;2024-07-10

2. Updates on clinical and laboratory aspects of hereditary dyserythropoietic anemias;International Journal of Laboratory Hematology;2024-05-15

3. Development of High-Resolution Melting Curve Analysis for rapid detection of SEC23B gene mutation causing Congenital Dyserythropoietic Anemia type II in Indian population;Italian Journal of Pediatrics;2023-07-16

4. Membrane Protein Detection and Morphological Analysis of Red Blood Cells in Hereditary Spherocytosis by Confocal Laser Scanning Microscopy;Microscopy and Microanalysis;2023-03-11

5. Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium;Transplantation and Cellular Therapy;2022-06